Biomarkers in Breast Cancer: Current Practice, Opportunities and Unmet Needs

Presented By: Jeffrey Peppercorn, PhD Speaker Biography: Dr. Jeffrey Peppercorn is a medical oncologist specializing in breast cancer who conducts research related to health policy, bioethics, and cancer survivorship. He serves at the Director of the MGH Cancer Center Supportive Care and Survivorship Program and is an Associate Professor of Medicine at Harvard Medical School. He also serves on the American Society of Clinical Oncology Research Committee and Chairs the Ethics Committee for the Alliance for Clinical Trials in Oncology. He has published over 150 papers and chapters on issues related to breast cancer care, research, and policy. Webinar: Biomarkers in Breast Cancer: Current Practice, Opportunities and Unmet Needs Webinar Abstract: Biomarkers are essential to define breast cancer subtypes that predict prognosis and guide treatment and to guide selection of Rx in metastatic disease. 94% of breast cancer is curable and biomarkers play a critical role in identifying patients with early stage cancer who may benefit from novel therapies. Biomarkers can be useful in evaluation of symptoms in survivors but should not be used in asymptomatic survivors outside of a clinical trial. More research is needed to identify high risk patients who can be targeted for early intervention and improved outcomes. CC Language: Korean

• #science_technology
• #webinar
• #labroots
• #biomarkers_in_breast_cancer
• #breast_cancer_subtypes
• #prognosis_and_guide_treatment
• #predicting_breast_cancer
• #breast_cancer_screening
• #liquid_biopsy